Royce & Associates LP PROGENICS PHARMACEUTICALS IN Transaction History

Royce & Associates LP

  • $9.25 Billion
  • Q2 2025

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 06, 2020
SELL
N/A
-974,439 Closed
0 $0
Q2 2019

Aug 12, 2019
SELL
N/A
-227,200 Reduced 18.91%
974,439 $6.01 Million
Q1 2019

May 09, 2019
SELL
N/A
-195,000 Reduced 13.96%
1,201,639 $5.58 Million
Q4 2018

Feb 11, 2019
SELL
N/A
-56,817 Reduced 3.91%
1,396,639 $5.87 Million
Q3 2018

Nov 13, 2018
BUY
N/A
276,200 Added 23.46%
1,453,456 $9.11 Million
Q2 2018

Aug 09, 2018
BUY
N/A
15,000 Added 1.29%
1,177,256 $9.47 Million
Q1 2018

May 14, 2018
SELL
N/A
-48,600 Reduced 4.01%
1,162,256 $8.67 Million
Q4 2017

Feb 09, 2018
SELL
N/A
-73,918 Reduced 5.75%
1,210,856 $7.21 Million
Q3 2017

Nov 13, 2017
SELL
N/A
-61,600 Reduced 4.58%
1,284,774 $9.46 Million
Q2 2017

Aug 07, 2017
BUY
N/A
1,346,374
1,346,374 $9.14 Million
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email